Clinical Trials Directory

Trials / Completed

CompletedNCT00275717

A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.

The Effects of Thymoglobulin on Antibody Screening Cells.

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by antibody producing cells.

Detailed description

Bone marrow and blood samples from both non-sensitized kidney transplant recipients and sensitized kidney transplant recipients will be collected. The samples will be used to compare the effect immunosuppression has on the antibody producing cells from both of these kinds of transplant recipients. Bone marrow will be collected from sensitized kidney transplant recipients before desensitization therapy prior to transplantation and at the time of kidney transplant surgery. Non-sensitized patients will have bone marrow collected only at the time of kidney transplant surgery. Blood will be collected at the same time point that the marrow is collected in both kinds of patients.

Conditions

Timeline

Start date
2005-03-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2006-01-12
Last updated
2010-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00275717. Inclusion in this directory is not an endorsement.

A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients. (NCT00275717) · Clinical Trials Directory